NextCure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.About NXTC
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.
CEOMichael S. Richman
CEOMichael S. Richman
Employees43
Employees43
HeadquartersBeltsville, Maryland
HeadquartersBeltsville, Maryland
Founded2015
Founded2015
Employees43
Employees43
NXTC Key Statistics
Market cap12.13M
Market cap12.13M
Price-Earnings ratio-0.25
Price-Earnings ratio-0.25
Dividend yield—
Dividend yield—
Average volume142.61K
Average volume142.61K
High today$0.439
High today$0.439
Low today$0.4226
Low today$0.4226
Open price$0.43
Open price$0.43
Volume86.06K
Volume86.06K
52 Week high$1.82
52 Week high$1.82
52 Week low$0.224
52 Week low$0.224
People also own
Based on the portfolios of people who own NXTC. This list is generated using Robinhood data, and it’s not a recommendation.